INV vs IRAB

Innventure, Inc. vs Iris Acquisition Corp II — Valuation Comparison 2026

INV

Blank Checks
Innventure, Inc.
Quality
5.4
out of 10
Value Trap
13
SAFE
Price
$5.33
Last close
Models
4/13
Active
VS

IRAB

Blank Checks
Iris Acquisition Corp II
Quality
3.3
out of 10
Value Trap
Price
$9.93
Last close
Models
6/13
Active

Model-by-Model Comparison

ModelType INV Fair ValueINV Upside IRAB Fair ValueIRAB Upside
Bayesian DCF Intrinsic $0.19 -96.4% $2.63 -73.5%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.31 -95.0% $4.10 -58.7%
PWERM Option-Based $3.78 -29.1% $9.27 -6.7%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for INV vs IRAB — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

INV vs IRAB — Which Stock Is More Undervalued?

INV scores higher with a 5.4/10 quality rating vs IRAB's 3.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Innventure, Inc. (INV) and Iris Acquisition Corp II (IRAB) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

INV currently trades at $5.33 with a QOC of 5.4/10, while IRAB trades at $9.93 with a QOC of 3.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).